Membrane transporters for the special amino acid glutamine: Structure/function relationships and relevance to human health

Frontiers in Chemistry

Volumn 2, Issue , 2014, Pages 1-23

  Pochini, Lorena ^a   Scalise, Mariafrancesca ^a   Galluccio, Michele ^a   Indiveri, Cesare ^a  

^a UNIVERSITY OF CALABRIA   (Italy)

Author keywords

Amino acids; Cancer; Glutamine; Homology models; Membrane; Nutrients; Transporters

Indexed keywords

EID: 84986915942     PISSN: None     EISSN: 22962646     Source Type: Journal    
DOI: 10.3389/fchem.2014.00061     Document Type: Article

References (211)

1. Abajian, C., and Rosenzweig, A. C. (2006). Crystal structure of yeast Sco1. J. Biol. Inorg. Chem. 11, 459-466. doi: 10.1007/s00775-006-0096-7
2. Albers, A., Broer, A., Wagner, C. A., Setiawan, I., Lang, P. A., Kranz, E. U., et al. (2001). Na+ transport by the neural glutamine transporter ATA1. Pfiugers Arch. 443, 92-101. doi: 10.1007/s004240100663
3. Albers, T., Marsiglia, W., Thomas, T., Gameiro, A., and Grewer, C. (2012). Defining substrate and blocker activity of alanine-serine-cysteine transporter (ASCT2) ligands with novel serine analogs. Mol. Pharmacol. 81, 356-365. doi: 10.1124/mol.111.075648
4. Amaral, J. S., Pinho, M. J., and Soares-Da-Silva, P. (2008). Genomic regulation of intestinal amino acid transporters by aldosterone.Mol. Cell. Biochem. 313, 1-10. doi: 10.1007/s11010-008-9735-3
5. Antony, J. M., Deslauriers, A. M., Bhat, R. K., Ellestad, K. K., and Power, C. (2011). Human endogenous retroviruses and multiple sclerosis: innocent bystanders or disease determinants? Biochim. Biophys. Acta 1812, 162-176. doi: 10.1016/j.bbadis.2010.07.016
6. Avissar, N. E., Sax, H. C., and Toia, L. (2008). In human entrocytes, GLN transportandASCT2surfaceexpressioninducedbyshort-termEGFareMAPK, PI3K, and Rho-dependent. Dig. Dis. Sci. 53, 2113-2125. doi: 10.1007/s10620-007-0120-y
7. Bak, L. K., Schousboe, A., and Waagepetersen, H. S. (2006). The glutamate/GABA-glutamine cycle: aspects of transport, neurotransmitter homeostasis and ammonia transfer. J. Neurochem. 98, 641-653. doi: 10.1111/j.1471-4159.2006.03913.x
8. Betsunoh, H., Fukuda, T., Anzai, N., Nishihara, D., Mizuno, T., Yuki, H., et al. (2013). Increased expression of system large amino acid transporter (LAT)-1 mRNA is associated with invasive potential and unfavorable prognosis of human clear cell renal cell carcinoma. BMC Cancer 13:509. doi: 10.1186/1471-2407-13-509
9. Bhavsar, S. K., Hosseinzadeh, Z.,Merches, K., Gu, S., Broer, S., and Lang, F. (2011). Stimulation of the amino acid transporter SLC6A19 by JAK2. Biochem. Biophys. Res. Commun. 414, 456-461. doi: 10.1016/j.bbrc.2011.09.074
10. Boado, R. J., Li, J. Y., Chu, C., Ogoshi, F., Wise, P., and Pardridge, W. M. (2005). Site-directed mutagenesis of cysteine residues of large neutral amino acid transporter LAT1. Biochim. Biophys. Acta 1715, 104-110. doi: 10.1016/j.bbamem.2005.07.007
11. Bode, B. P. (2001). Recent molecular advances in mammalian glutamine transport. J. Nutr. 131, 2475S-2485S. discussion: 2486S-2477S. doi: 10.1146/annurev.nutr. 13.1.137
12. Bode, B. P., Fuchs, B. C., Hurley, B. P., Conroy, J. L., Suetterlin, J. E., Tanabe, K. K., et al. (2002). Molecular and functional analysis of glutamine uptake in human hepatoma and liver-derived cells. Am. J. Physiol. Gastrointest. Liver Physiol. 283, G1062-G1073. doi: 10.1152/ajpgi.00031.2002
13. Bodoy, S., Fotiadis, D., Stoeger, C., Kanai, Y., and Palacin, M. (2013). The small SLC43 family: facilitator systeml amino acid transporters and the orphan EEG1. Mol. Aspects Med. 34, 638-645. doi: 10.1016/j.mam.2012.12.006
14. Bogatikov, E., Munoz, C., Pakladok, T., Alesutan, I., Shojaiefard, M., Seebohm, G., et al. (2012). Up-regulation of amino acid transporter SLC6A19 activity and surface protein abundance by PKB/Akt and PIKfyve. Cell. Physiol. Biochem. 30, 1538-1546. doi: 10.1159/000343341
15. Bohmer, C., Broer, A., Munzinger, M., Kowalczuk, S., Rasko, J. E., Lang, F., et al. (2005). Characterization of mouse amino acid transporter B0AT1 (slc6a19). Biochem. J. 389, 745-751. doi: 10.1042/BJ20050083
16. Bohmer, C., Sopjani, M., Klaus, F., Lindner, R., Laufer, J., Jeyaraj, S., et al. (2010). The serum and glucocorticoid inducible kinases SGK1-3 stimulate the neutral amino acid transporter SLC6A19. Cell.Physiol.Biochem. 25, 723-732. doi: 10.1159/000315092
17. Boudker, O., Ryan, R. M., Yernool, D., Shimamoto, K., and Gouaux, E. (2007). Coupling substrate and ion binding to extracellular gate of a sodium-dependent aspartate transporter. Nature 445, 387-393. doi: 10.1038/nature05455
18. Brizio, C., Galluccio, M., Wait, R., Torchetti, E. M., Bafunno, V., Accardi, R., et al. (2006). Over-expression in Escherichia coli and characterization of two recombinant isoforms of human FAD synthetase. Biochem. Biophys. Res. Commun. 344, 1008-1016. doi: 10.1016/j.bbrc.2006.04.003
19. Broer, A., Brookes, N., Ganapathy, V., Dimmer, K. S., Wagner, C. A., Lang, F., et al. (1999). The astroglial ASCT2 amino acid transporter as amediator of glutamine effiux. J. Neurochem. 73, 2184-2194.
20. Broer, A., Friedrich, B., Wagner, C. A., Fillon, S., Ganapathy, V., Lang, F., et al. (2001). Association of 4F2hc with light chains LAT1, LAT2 or y+LAT2 requires different domains. Biochem. J. 355, 725-731.
21. Broer, A., Juelich, T., Vanslambrouck, J. M., Tietze, N., Solomon, P. S., Holst, J., et al. (2011). Impaired nutrient signaling and body weight control in a Na+ neutral amino acid cotransporter (Slc6a19)-deficient mouse. J. Biol. Chem. 286, 26638-26651. doi: 10.1074/jbc.M111.241323
22. Broer, A., Klingel, K., Kowalczuk, S., Rasko, J. E., Cavanaugh, J., and Broer, S. (2004). Molecular cloning of mouse amino acid transport system B0, a neutral amino acid transporter related to Hartnup disorder. J. Biol. Chem. 279, 24467-24476. doi: 10.1074/jbc.M400904200
23. Broer, A., Wagner, C. A., Lang, F., and Broer, S. (2000). The heterodimeric amino acid transporter 4F2hc/y+LAT2 mediates arginine effiux in exchange with glutamine. Biochem. J. 349(Pt 3), 787-795.
24. Broer, S. (2006). The SLC6 orphans are forming a family of amino acid transporters. Neurochem. Int. 48, 559-567. doi: 10.1016/j.neuint.2005.11.021
25. Broer, S. (2008). Apical transporters for neutral amino acids: physiology and patho-physiology. Physiology (Bethesda) 23, 95-103. doi: 10.1152/physiol.00045.2007
26. Broer, S. (2009). The role of the neutral amino acid transporter B0AT1 (SLC6A19) in Hartnup disorder and protein nutrition. IUBMB Life 61, 591-599. doi: 10.1002/iub.210
27. Broer, S. (2014). The SLC38 family of sodium-amino acid co-transporters. Pfiugers Arch. 466, 155-172. doi: 10.1007/s00424-013-1393-y
28. Broer, S., and Brookes, N. (2001). Transfer of glutamine between astrocytes and neurons. J. Neurochem. 77, 705-719. doi: 10.1046/j.1471-4159.2001.00322.x
29. Bungard, C. I., and McGivan, J. D. (2004). Glutamine availability upregulates expression of the amino acid transporter protein ASCT2 in HepG2 cells and stimulates the ASCT2 promoter. Biochem. J. 382, 27-32. doi: 10.1042/BJ20040487
30. Bungard, C. I., and McGivan, J. D. (2005). Identification of the promoter elements involved in the stimulation of ASCT2 expression by glutamine availability in HepG2 cells and the probable involvement of FXR/RXR dimers. Arch. Biochem. Biophys. 443, 53-59. doi: 10.1016/j.abb.2005.08.016
31. Busque, S., Leventhal, J., Brennan, D. C., Steinberg, S., Klintmalm, G., Shah, T., et al. (2009). Calcineurin-inhibitor-free immunosuppression based on the JAK inhibitor CP-690,550: a pilot study in de novo kidney allograft recipients. Am. J. Transplant. 9, 1936-1945. doi: 10.1111/j.1600-6143.2009.02720.x
32. Busque, S.M., andWagner, C. A. (2009). Potassiumrestriction, high protein intake, and metabolic acidosis increase expression of the glutamine transporter SNAT3 (Slc38a3) in mouse kidney. Am. J. Physiol. Renal Physiol. 297, F440-F450. doi: 10.1152/ajprenal.90318.2008
33. Camargo, S. M., Makrides, V., Virkki, L. V., Forster, I. C., and Verrey, F. (2005). Steady-state kinetic characterization of the mouse B(0)AT1 sodium-dependent neutral amino acid transporter. Pfiugers Arch. 451, 338-348. doi: 10.1007/s00424-005-1455-x
34. Cantor, J. M., and Ginsberg, M. H. (2012). CD98 at the crossroads of adaptive immunity and cancer. J. Cell Sci. 125, 1373-1382. doi: 10.1242/jcs.096040
35. Chaudhry, F. A., Krizaj, D., Larsson, P., Reimer, R. J., Wreden, C., Storm-Mathisen, J., et al. (2001). Coupled and uncoupled proton movement by amino acid transport system N. EMBO J. 20, 7041-7051. doi: 10.1093/emboj/20. 24.7041
36. Chaudhry, F. A., Reimer, R. J., Krizaj, D., Barber, D., Storm-Mathisen, J., Copenhagen, D. R., et al. (1999). Molecular analysis of system N suggests novel physiological roles in nitrogen metabolism and synaptic transmission. Cell 99, 769-780.
37. Chaudhry, F. A., Schmitz, D., Reimer, R. J., Larsson, P., Gray, A. T., Nicoll, R., et al. (2002). Glutamine uptake by neurons: interaction of protons with system atransporters. J. Neurosci. 22, 62-72.
38. Chen, J. Q., and Russo, J. (2012). Dysregulation of glucose transport, glycolysis, TCA cycle and glutaminolysis by oncogenes and tumor suppressors in cancer cells. Biochim. Biophys. Acta 1826, 370-384. doi: 10.1016/j.bbcan.2012.06.004
39. Christensen, H. N. (1990). Role of amino acid transport and countertransport in nutrition and metabolism. Physiol. Rev. 70, 43-77.
40. Christensen, H. N., Oxender, D. L., Liang,M., and Vatz, K. A. (1965). The use of N-methylation to direct route of mediated transport of amino acids. J. Biol. Chem. 240, 3609-3616.
41. Conti, F., and Melone, M. (2006). The glutamine commute: lost in the tube? Neurochem. Int. 48, 459-464. doi: 10.1016/j.neuint.2005.11.016
42. Costa, M., Rosell, A., Alvarez-Marimon, E., Zorzano, A., Fotiadis, D., and Palacin, M. (2013). Expression of human heteromeric amino acid transporters in the yeast Pichia pastoris. Protein Expr. Purif. 87, 35-40. doi: 10.1016/j.pep.2012.10.003
43. Curi,R.,Lagranha,C.J.,Doi,S.Q.,Sellitti,D.F.,Procopio,J.,Pithon-Curi,T.C., et al. (2005). Molecular mechanisms of glutamine action. J. Cell. Physiol. 204, 392-401. doi: 10.1002/jcp.20339
44. Cynober, L. A. (2002). Plasma amino acid levels with a note on membrane transport: characteristics, regulation, and metabolic significance. Nutrition 18, 761-766. doi: 10.1016/S0899-9007(02)00780-3
45. Dang, C. V. (2010). p32 (C1QBP) and cancer cellmetabolism: is theWarburg effect alotofhotair? Mol. Cell. Biol. 30, 1300-1302. doi: 10.1128/MCB.01661-09
46. Danilczyk, U., Sarao, R., Remy, C., Benabbas, C., Stange, G., Richter, A., et al. (2006). Essential role for collectrin in renal amino acid transport. Nature 444, 1088-1091. doi: 10.1038/nature05475
47. Daye, D., and Wellen, K. E. (2012).Metabolic reprogramming in cancer: unraveling theroleofglutamineintumorigenesis. Semin. Cell Dev. Biol. 23, 362-369. doi: 10.1016/j.semcdb.2012.02.002
48. Deberardinis, R. J., Lum, J. J., Hatzivassiliou, G., and Thompson, C. B. (2008). The biology of cancer:metabolic reprogramming fuels cell growth and proliferation. Cell Metab. 7, 11-20. doi: 10.1016/j.cmet.2007.10.002
49. Deberardinis, R. J., Mancuso, A., Daikhin, E., Nissim, I., Yudkoff, M., Wehrli, S., et al. (2007). Beyond aerobic glycolysis: transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis. Proc. Natl. Acad. Sci. U.S.A. 104, 19345-19350. doi: 10.1073/pnas.0709747104
50. Deitmer, J. W., Broer, A., and Broer, S. (2003). Glutamine effiux from astrocytes is mediated bymultiple pathways. J. Neurochem. 87, 127-135. doi: 10.1046/j.1471-4159.2003.01981.x
51. Del Amo, E. M., Urtti, A., and Yliperttula, M. (2008). Pharmacokinetic role of L-type amino acid transporters LAT1 and LAT2. Eur. J. Pharm. Sci. 35, 161-174. doi: 10.1016/j.ejps.2008.06.015
52. Deng, D., Xu, C., Sun, P., Wu, J., Yan, C., Hu, M., et al. (2014). Crystal structure of the human glucose transporter GLUT1. Nature 510, 121-125. doi: 10.1038/ nature13306
53. Dolinska, M., Dybel, A., Zablocka, B., and Albrecht, J. (2003). Glutamine transport in C6 glioma cells shows ASCT2 system characteristics. Neurochem. Int. 43, 501-507. doi: 10.1016/S0197-0186(03)00040-8
54. Drummond, M. J., Glynn, E. L., Fry, C. S., Timmerman, K. L., Volpi, E., and Rasmussen, B. B. (2010). An increase in essential amino acid availability upregulates amino acid transporter expression in human skeletal muscle. Am. J. Physiol. Endocrinol. Metab. 298, E1011-E1018. doi: 10.1152/ajpendo. 00690.2009
55. Ducroc, R., Sakar, Y., Fanjul, C., Barber, A., Bado, A., and Lostao, M. P. (2010). Luminal leptin inhibits L-glutamine transport in rat small intestine: involvement of ASCT2 and B0AT1. Am. J. Physiol. Gastrointest. Liver Physiol. 299, G179-G185. doi: 10.1152/ajpgi.00048.2010
56. Ebara, T., Kaira, K., Saito, J., Shioya, M., Asao, T., Takahashi, T., et al. (2010). L-type amino-acid transporter 1 expression predicts the response to preoperative hyperthermo-chemoradiotherapy for advanced rectal cancer. Anticancer Res. 30, 4223-4227.
57. El-Gebali, S., Bentz, S., Hediger, M. A., and Anderle, P. (2013). Solute carriers (SLCs) in cancer. Mol. Aspects Med. 34, 719-734. doi: 10.1016/j.mam.2012. 12.007
58. Fairweather, S. J., Broer, A., O'mara, M. L., and Broer, S. (2012). Intestinal pep-tidases form functional complexes with the neutral amino acid transporter B(0)AT1. Biochem. J. 446, 135-148. doi: 10.1042/BJ20120307
59. Fernandez, E., Torrents, D., Zorzano, A., Palacin, M., and Chillaron, J. (2005). Identification and functional characterization of a novel low affinity aromatic-preferring amino acid transporter (arpAT). One of the few proteins silenced during primate evolution. J. Biol. Chem. 280, 19364-19372. doi: 10.1074/jbc.M412516200
60. Forrest, L. R., Kramer, R., and Ziegler, C. (2011). The structural basis of secondary active transportmechanisms. Biochim. Biophys. Acta 1807, 167-188. doi: 10.1016/j.bbabio.2010.10.014
61. Fort, J., De La Ballina, L. R., Burghardt, H. E., Ferrer-Costa, C., Turnay, J., Ferrer-Orta, C., et al. (2007). The structure of human 4F2hc ectodomain provides a model for homodimerization and electrostatic interaction with plasma membrane. J. Biol. Chem. 282, 31444-31452. doi: 10.1074/jbc. M704524200
62. Fotiadis, D., Kanai, Y., and Palacin, M. (2013). The SLC3 and SLC7 families of amino acid transporters. Mol. Aspects Med. 34, 139-158. doi: 10.1016/j.mam.2012.10.007
63. Fraga, S., Pinho, M. J., and Soares-Da-Silva, P. (2005). Expression of LAT1 and LAT2 amino acid transporters in human and rat intestinal epithelial cells. Amino Acids 29, 229-233. doi: 10.1007/s00726-005-0221-x
64. Franca, R., Veljkovic, E., Walter, S., Wagner, C. A., and Verrey, F. (2005). Heterodimeric amino acid transporter glycoprotein domains determining functional subunit association. Biochem. J. 388, 435-443. doi: 10.1042/BJ20050021
65. Fuchs, B. C., and Bode, B. P. (2005). Amino acid transporters ASCT2 and LAT1 in cancer: partners in crime? Semin. Cancer Biol. 15, 254-266. doi: 10.1016/j.semcancer.2005.04.005
66. Fuchs, B. C., Finger, R. E., Onan, M. C., and Bode, B. P. (2007). ASCT2 silencing regulates mammalian target-of-rapamycin growth and survival signaling in human hepatoma cells. Am.J.Physiol.CellPhysiol. 293, C55-C63. doi: 10.1152/ajpcell.00330.2006
67. Fuchs, B. C., Perez, J. C., Suetterlin, J. E., Chaudhry, S. B., and Bode, B. P. (2004). Inducible antisense RNA targeting amino acid transporter ATB0/ASCT2 elicits apoptosis in human hepatoma cells. Am. J. Physiol. Gastrointest. Liver Physiol. 286, G467-G478. doi: 10.1152/ajpgi.00344.2003
68. Furuya, M., Horiguchi, J., Nakajima, H., Kanai, Y., and Oyama, T. (2012). Correlation of L-type amino acid transporter 1 and CD98 expression with triple negative breast cancer prognosis. Cancer Sci. 103, 382-389. doi: 10.1111/j.1349-7006.2011.02151.x
69. Galluccio,M., Pingitore, P., Scalise,M., and Indiveri, C. (2013). Cloning, large scale over-expression in E. coli and purification of the components of the human LAT 1 (SLC7A5) amino acid transporter. Protein J. 32, 442-448. doi: 10.1007/s10930-013-9503-4G7A
70. Ganapathy, M. E., and Ganapathy, V. (2005). Amino Acid Transporter ATB0,+ as a delivery system for drugs and prodrugs. Curr. Drug Targets Immune Endocr. Metabol. Disord. 5, 357-364. doi: 10.2174/156800805774912953
71. Ganapathy, V., Thangaraju, M., and Prasad, P. D. (2009). Nutrient transporters in cancer: relevance to Warburg hypothesis and beyond. Pharmacol. Ther. 121, 29-40. doi: 10.1016/j.pharmthera.2008.09.005
72. Gao, P., Tchernyshyov, I., Chang, T. C., Lee, Y. S., Kita, K., Ochi, T., et al. (2009). c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism. Nature 458, 762-765. doi: 10.1038/ nature07823
73. Geier, E. G., Schlessinger, A., Fan, H., Gable, J. E., Irwin, J. J., Sali, A., et al. (2013). Structure-based ligand discovery for the large-neutral amino acid transporter 1, LAT-1. Proc. Natl. Acad. Sci. U.S.A. 110, 5480-5485. doi: 10.1073/pnas.1218165110
74. Giacomini, K. M., Huang, S. M., Tweedie, D. J., Benet, L. Z., Brouwer, K. L., Chu, X., et al. (2010). Membrane transporters in drug development. Nat. Rev. Drug Discov. 9, 215-236. doi: 10.1038/nrd3028
75. Gliddon, C. M., Shao, Z., Lemaistre, J. L., and Anderson, C. M. (2009). Cellular distribution of the neutral amino acid transporter subtype ASCT2 in mouse brain. J. Neurochem. 108, 372-383. doi: 10.1111/j.1471-4159.2008. 05767.x
76. Grewer, C., and Grabsch, E. (2004). New inhibitors for the neutral amino acid transporter ASCT2 reveal its Na+-dependent anion leak. J. Physiol. 557, 747-759. doi: 10.1113/jphysiol.2004.062521
77. Gupta, N., Miyauchi, S., Martindale, R. G., Herdman, A. V., Podolsky, R., Miyake, K., et al. (2005). Upregulation of the amino acid transporter ATB0,+ (SLC6A14) in colorectal cancer and metastasis in humans. Biochim. Biophys. Acta 1741, 215-223. doi: 10.1016/j.bbadis.2005.04.002
78. Gupta, N., Prasad, P. D., Ghamande, S., Moore-Martin, P., Herdman, A. V., Martindale, R. G., et al. (2006). Up-regulation of the amino acid transporter ATB(0,+) (SLC6A14) in carcinoma of the cervix. Gynecol. Oncol. 100, 8-13. doi: 10.1016/j.ygyno.2005.08.016
79. Hagglund, M. G., Sreedharan, S., Nilsson, V. C., Shaik, J. H., Almkvist, I. M., Backlin, S., et al. (2011). Identification of SLC38A7 (SNAT7) protein as a glutamine transporter expressed in neurons. J. Biol. Chem. 286, 20500-20511. doi: 10.1074/jbc.M110.162404
80. Halestrap, A. P. (2013). The SLC16 gene family-structure, role and regulation in health and disease. Mol. Aspects Med. 34, 337-349. doi: 10.1016/j.mam.2012.05.003
81. Hamdi,M.M., and Mutungi, G. (2011).Dihydrotestosterone stimulates amino acid uptake and the expression of LAT2 in mouse skeletal muscle fibres through an ERK1/2-dependent mechanism. J. Physiol. 589, 3623-3640. doi: 10.1113/jphys-iol.2011.207175
82. Hansen, I. A., Boudko, D. Y., Shiao, S. H., Voronov, D. A., Meleshkevitch, E. A., Drake, L. L., et al. (2011). AaCAT1 of the yellow fever mosquito, Aedes aegypti: a novel histidine-specific amino acid transporter from the SLC7 family. J. Biol. Chem. 286, 10803-10813. doi: 10.1074/jbc.M110.179739
83. Hassanein, M., Hoeksema, M. D., Shiota, M., Qian, J., Harris, B. K., Chen, H., et al. (2013). SLC1A5 mediates glutamine transport required for lung cancer cell growth and survival. Clin. Cancer Res. 19, 560-570. doi: 10.1158/1078-0432.CCR-12-2334
84. Hayashi, K., Jutabha, P., Endou, H., and Anzai, N. (2012). c-Myc is crucial for the expression of LAT1 in MIA Paca-2 human pancreatic cancer cells. Oncol. Rep. 28, 862-866. doi: 10.3892/or.2012.1878
85. Herzig, S., Raemy, E., Montessuit, S., Veuthey, J. L., Zamboni, N., Westermann, B., et al. (2012). Identification and functional expression of the mitochondrial pyruvate carrier. Science 337, 93-96. doi: 10.1126/science.1218530
86. Holecek, M. (2013). Side effects of long-term glutamine supplementation. JPEN J. Parenter. Enteral Nutr. 37, 607-616. doi: 10.1177/0148607112460682
87. Imai, H., Kaira, K., Oriuchi, N., Shimizu, K., Tominaga, H., Yanagitani, N., et al. (2010). Inhibition of L-type amino acid transporter 1 has antitumor activity in non-small cell lung cancer. Anticancer Res. 30, 4819-4828.
88. Indiveri, C., Abruzzo, G., Stipani, I., and Palmieri, F. (1998). Identification and purification of the reconstitutively active glutamine carrier from rat kidney mitochondria. Biochem. J. 333(Pt 2), 285-290.
89. Indiveri, C., Galluccio, M., Scalise, M., and Pochini, L. (2013). Strategies of bacterial over expression of membrane transporters relevant in human health: the successful case of the three members of OCTN subfamily. Mol. Biotechnol. 54, 724-736. doi: 10.1007/s12033-012-9586-8
90. Indiveri, C., Palmieri, L., and Palmieri, F. (1994). Kinetic characterization of the reconstituted ornithine carrier from rat liver mitochondria. Biochim. Biophys. Acta 1188, 293-301. doi: 10.1016/0005-2728(94)90048-5
91. Indiveri, C., Pochini, L., Galluccio, M., and Scalise, M. (2014). SLC1A5 (solute carrier family 1 (neutral amino acid transporter), member 5). Atlas Genet. Cytogenet. Oncol. Haematol. Available online at: http://AtlasGeneticsOncology. org/Genes/SLC1A5ID42313ch19q13.html
92. Jenstad, M., and Chaudhry, F. A. (2013). The amino acid transporters of the glutamate/GABA-glutamine cycle and their impact on insulin and glucagon secretion. Front. Endocrinol. (Lausanne) 4:199. doi: 10.3389/fendo.2013.00199
93. Jordan, I. K., Kondrashov, F. A., Adzhubei, I. A., Wolf, Y. I., Koonin, E. V., Kondrashov, A. S., et al. (2005). A universal trend of amino acid gain and loss in protein evolution. Nature 433, 633-638. doi: 10.1038/nature03306
94. Kageyama, T., Nakamura, M., Matsuo, A., Yamasaki, Y., Takakura, Y., Hashida, M., et al. (2000). The 4F2hc/LAT1 complex transports L-DOPA across the blood-brain barrier. Brain Res. 879, 115-121. doi: 10.1016/S0006-8993(00) 02758-X
95. Kaira, K., Oriuchi, N., Imai, H., Shimizu, K., Yanagitani, N., Sunaga, N., et al. (2010). Prognostic significance of L-type amino acid transporter 1 (LAT1) and 4F2 heavy chain (CD98) expression in surgically resectable stage III non-small cell lung cancer. Exp. Ther. Med. 1, 799-808. doi: 10.3892/etm.2010.117
96. Kaira, K., Oriuchi, N., Takahashi, T., Nakagawa, K., Ohde, Y., Okumura, T., et al. (2011). L-type amino acid transporter 1 (LAT1) expression inmalignant pleural mesothelioma. Anticancer Res. 31, 4075-4082.
97. Kaira, K., Sunose, Y., Ohshima, Y., Ishioka, N. S., Arakawa, K., Ogawa, T., et al. (2013). Clinical significance of L-type amino acid transporter 1 expression as a prognosticmarker and potential of new targeting therapy in biliary tract cancer. BMC Cancer 13:482. doi: 10.1186/1471-2407-13-482
98. Kaji, M., Kabir-Salmani, M., Anzai, N., Jin, C. J., Akimoto, Y., Horita, A., et al. (2010). Properties of L-type amino acid transporter 1 in epidermal ovarian cancer. Int. J. Gynecol. Cancer 20, 329-336. doi: 10.1111/IGC.0b013e3181d28e13
99. Kanai, Y., Clemencon, B., Simonin, A., Leuenberger, M., Lochner, M., Weisstanner, M., et al. (2013). The SLC1 high-affinity glutamate and neutral amino acid transporter family. Mol. Aspects Med. 34, 108-120. doi: 10.1016/j.mam.2013.01.001
100. Kanai, Y., Segawa, H.,Miyamoto, K., Uchino, H., Takeda, E., and Endou, H. (1998). Expression cloning and characterization of a transporter for large neutral amino acids activated by the heavy chain of 4F2 antigen (CD98). J. Biol. Chem. 273, 23629-23632. doi: 10.1074/jbc.273.37.23629
101. Karunakaran, S., Ramachandran, S., Coothankandaswamy, V., Elangovan, S., Babu, E., Periyasamy-Thandavan, S., et al. (2011). SLC6A14 (ATB0,+) protein, a highly concentrative and broad specific amino acid transporter, is a novel and effective drug target for treatment of estrogen receptor-positive breast cancer. J. Biol. Chem. 286, 31830-31838. doi: 10.1074/jbc.M111.229518
102. Katt, W. P., and Cerione, R. A. (2014). Glutaminase regulation in cancer cells: a druggable chain of events. Drug Discov. Today 19, 450-457. doi: 10.1016/j.drudis.2013.10.008
103. Kekuda, R., Prasad, P. D., Fei, Y. J., Torres-Zamorano, V., Sinha, S., Yang-Feng, T. L., et al. (1996). Cloning of the sodium-dependent, broad-scope, neutral amino acid transporter Bo from a human placental choriocarcinoma cell line. J. Biol. Chem. 271, 18657-18661. doi: 10.1074/jbc.271.31.18657
104. Kekuda, R., Torres-Zamorano, V., Fei, Y. J., Prasad, P. D., Li, H. W., Mader, L. D., et al. (1997). Molecular and functional characterization of intestinal Na(+)-dependent neutral amino acid transporter B0. Am. J. Physiol. 272, G1463-G1472.
105. Kilberg, M. S., and Christensen, H. N. (1980). The relation between membrane potential and the transport activity of system A and L in plasma membrane vesicles of the Ehrlich cell. Membr. Biochem. 3, 155-168. doi: 10.3109/09687688009063883
106. Kim, M. S., Park, Y. S., Kim, S. H., Kim, S. Y., Lee, M. H., Kim, Y. H., et al. (2012). Quantification of nimesulide in human plasma by high-performance liquid chromatography with ultraviolet detector (HPLC-UV): application to pharmacokinetic studies in 28 healthy Korean subjects. J. Chromatogr. Sci. 50, 396-400. doi: 10.1093/chromsci/bms014
107. Kinne, A., Schulein, R., and Krause, G. (2011). Primary and secondary thyroid hormone transporters. Thyroid Res. 4(Suppl. 1), S7. doi: 10.1186/1756-6614-4-S1-S7
108. Kleta, R., Romeo, E., Ristic, Z.,Ohura, T., Stuart, C., Arcos-Burgos,M., et al. (2004). Mutations in SLC6A19, encoding B0AT1, cause Hartnup disorder. Nat. Genet. 36, 999-1002. doi: 10.1038/ng1405
109. Kondoh, N., Imazeki, N., Arai,M., Hada, A., Hatsuse, K.,Matsuo, H., et al. (2007). Activation of a system A amino acid transporter, ATA1/SLC38A1, in human hepatocellular carcinoma and preneoplastic liver tissues. Int. J. Oncol. 31, 81-87. doi: 10.3892/ijo.31.1.81
110. Kondou, H., Kawai, M., Tachikawa, K., Kimoto, A., Yamagata, M., Koinuma, T., et al. (2013). Sodium-coupled neutral amino acid transporter 4 functions as a regulator of protein synthesis during liver development. Hepatol. Res. 43, 1211-1223. doi: 10.1111/hepr.12069
111. Krishnamurthy, H., and Gouaux, E. (2012). X-ray structures of LeuT in substrate-free outward-open and apo inward-open states. Nature 481, 469-474. doi: 10.1038/nature10737
112. Kurayama, R., Ito, N., Nishibori, Y., Fukuhara, D., Akimoto, Y., Higashihara, E., et al. (2011). Role of amino acid transporter LAT2 in the activation of mTORC1 pathway and the pathogenesis of crescentic glomerulonephritis. Lab. Invest. 91, 992-1006. doi: 10.1038/labinvest.2011.43
113. Li, J., Qiang, J., Chen, S. F., Wang, X., Fu, J., and Chen, Y. (2013). The impact of L-type amino acid transporter 1 (LAT1) in human hepatocellular carcinoma. Tumour Biol. 34, 2977-2981. doi: 10.1007/s13277-013-0861-5
114. Ma, D., Lu, P., Yan, C., Fan, C., Yin, P., Wang, J., et al. (2012). Structure and mechanism of a glutamate-GABA antiporter. Nature 483, 632-636. doi: 10.1038/nature10917
115. Mackenzie, B., and Erickson, J. D. (2004). Sodium-coupled neutral amino acid (System N/A) transporters of the SLC38 gene family. Pfiugers Arch. 447, 784-795. doi: 10.1007/s00424-003-1117-9
116. Mackenzie,B.,Schafer,M.K.,Erickson,J.D.,Hediger,M.A.,Weihe,E.,and Varoqui,H. (2003). Functional properties and cellular distribution of the system a glutamine transporter SNAT1 support specialized roles in central neurons. J. Biol. Chem. 278, 23720-23730. doi: 10.1074/jbc.M212718200
117. Marin, M., Lavillette, D., Kelly, S. M., and Kabat, D. (2003). N-linked glycosylation and sequence changes in a critical negative control region of the ASCT1 and ASCT2 neutral amino acid transporters determine their retroviral receptor functions. J. Virol. 77, 2936-2945. doi: 10.1128/JVI.77.5.2936-2945.2003
118. Mastroberardino,L.,Spindler,B.,Pfeiffer,R.,Skelly,P.J.,Loffing,J.,Shoemaker, C. B., et al. (1998). Amino-acid transport by heterodimers of 4F2hc/CD98 and members of a permease family. Nature 395, 288-291. doi: 10.1038/ 26246
119. Matsuyama, R., Tomi,M., Akanuma, S., Tabuchi, A., Kubo, Y., Tachikawa,M., et al. (2012). Up-regulation of L-type amino acid transporter 1 (LAT1) in cultured rat retinal capillary endothelial cells in response to glucose deprivation. Drug Metab. Pharmacokinet. 27, 317-324. doi: 10.2133/dmpk.DMPK-11-RG-122
120. McGivan, J. D., and Bungard, C. I. (2007). The transport of glutamine into mammalian cells. Front. Biosci. 12:874-882. doi: 10.2741/2109
121. Metallo, C. M. (2012). Expanding the reach of cancer metabolomics. Cancer Prev. Res. (Phila.) 5, 1337-1340. doi: 10.1158/1940-6207.CAPR-12-0433
122. Miroux, B., and Walker, J. E. (1996). Over-production of proteins in Escherichia coli:mutant hosts that allow synthesis of somemembrane proteins and globular proteins at high levels. J. Mol. Biol. 260, 289-298. doi: 10.1006/jmbi.1996.0399
123. Nakanishi, T., Hatanaka, T., Huang, W., Prasad, P. D., Leibach, F. H., Ganapathy, M. E., et al. (2001). Na+-and Cl-coupled active transport of carnitine by the amino acid transporter ATB(0,+) from mouse colon expressed in HRPE cells and Xenopus oocytes. J. Physiol. 532, 297-304. doi: 10.1111/j.1469-7793.2001.0297f.x
124. Newsholme, P., Procopio, J., Lima, M. M., Pithon-Curi, T. C., and Curi, R. (2003). Glutamine and glutamate-their central role in cell metabolism and function. Cell Biochem. Funct. 21, 1-9. doi: 10.1002/cbf.1003
125. Nicklin, P., Bergman, P., Zhang, B., Triantafellow, E., Wang, H., Nyfeler, B., et al. (2009). Bidirectional transport of amino acids regulates mTOR and autophagy. Cell 136, 521-534. doi: 10.1016/j.cell.2008.11.044
126. Nii, T., Segawa, H., Taketani, Y., Tani, Y., Ohkido, M., Kishida, S., et al. (2001). Molecular events involved in up-regulating human Na+-independent neutral amino acid transporter LAT1 during T-cell activation. Biochem. J. 358, 693-704. doi: 10.1042/0264-6021:3580693
127. Nissen-Meyer, L. S., and Chaudhry, F. A. (2013). Protein kinase C phosphorylates the system N glutamine transporter SN1 (Slc38a3) and regulates its membrane trafficking and degradation. Front. Endocrinol. (Lausanne) 4:138. doi: 10.3389/fendo.2013.00138
128. Ogura, M., Taniura, H., Nakamichi, N., and Yoneda, Y. (2007). Upregulation of the glutamine transporter through transactivation mediated by cAMP/protein kinase a signals toward exacerbation of vulnerability to oxidative stress in rat neocortical astrocytes. J. Cell. Physiol. 212, 375-385. doi: 10.1002/jcp.21031
129. Ohh, M. (2012). Tumor strengths and frailties: cancer SUMmOns Otto's metabolism. Nat. Med. 18, 30-31. doi: 10.1038/nm.2631
130. Ohno, H., Nakatsu, Y., Sakoda, H., Kushiyama, A., Ono, H., Fujishiro, M., et al. (2011). 4F2hc stabilizes GLUT1 protein and increases glucose transport activity. Am.J.Physiol.CellPhysiol. 300, C1047-C1054. doi: 10.1152/ajpcell.004 16.2010
131. Okudaira, H., Shikano, N., Nishii, R., Miyagi, T., Yoshimoto, M., Kobayashi, M., et al. (2011). Putative transport mechanism and intracellular fate of trans-1-amino-3-18F-fluorocyclobutanecarboxylic acid in human prostate cancer. J. Nucl. Med. 52, 822-829. doi: 10.2967/jnumed.110.086074
132. O'mara, M., Oakley, A., and Broer, S. (2006). Mechanism and putative structure of B(0)-like neutral amino acid transporters. J. Membr. Biol. 213, 111-118. doi: 10.1007/s00232-006-0879-3
133. Oppedisano, F., Catto, M., Koutentis, P. A., Nicolotti, O., Pochini, L., Koyioni, M., et al. (2012). Inactivation of the glutamine/amino acid transporter ASCT2 by 1,2,3-dithiazoles: proteoliposomes as a tool to gain insights in the molecular mechanism of action and of antitumor activity. Toxicol. Appl. Pharmacol. 265, 93-102. doi: 10.1016/j.taap.2012.09.011
134. Oppedisano, F., Galluccio, M., and Indiveri, C. (2010). Inactivation by Hg2+ and methylmercury of the glutamine/amino acid transporter (ASCT2) reconstituted in liposomes: Prediction of the involvement of a CXXC motif by homology modelling. Biochem. Pharmacol. 80, 1266-1273. doi: 10.1016/j.bcp.2010.06.032
135. Oppedisano, F., and Indiveri, C. (2008). Reconstitution into liposomes of the B degrees -like glutamine-neutral amino acid transporter from renal cell plasma membrane. Biochim. Biophys. Acta 1778, 2258-2265. doi: 10.1016/j.bbamem.2008.05.011
136. Oppedisano, F., Pochini, L., Broer, S., and Indiveri, C. (2011). The B degrees AT1 amino acid transporter fromrat kidney reconstituted in liposomes: kinetics and inactivation by methylmercury. Biochim. Biophys. Acta 1808, 2551-2558. doi: 10.1016/j.bbamem.2011.05.011
137. Oppedisano, F., Pochini, L., Galluccio, M., Cavarelli, M., and Indiveri, C. (2004). Reconstitution into liposomes of the glutamine/amino acid transporter from renal cell plasma membrane: functional characterization, kinetics and activation by nucleotides. Biochim. Biophys. Acta 1667, 122-131. doi: 10.1016/j.bbamem.2004.09.007
138. Oppedisano, F., Pochini, L., Galluccio, M., and Indiveri, C. (2007). The glutamine/amino acid transporter (ASCT2) reconstituted in liposomes: transport mechanism, regulation by ATP and characterization of the glutamine/glutamate antiport. Biochim. Biophys. Acta 1768, 291-298. doi: 10.1016/j.bbamem.2006.09.002
139. Ortiz, V., Aleman, G., Escamilla-Del-Arenal, M., Recillas-Targa, F., Torres, N., and Tovar, A. R. (2011). Promoter characterization and role of CRE in the basal transcription of the rat SNAT2 gene. Am. J. Physiol. Endocrinol. Metab. 300, E1092-E1102. doi: 10.1152/ajpendo.00459.2010
140. Oxender, D. L., and Christensen, H. N. (1963). Evidence for two types ofmediation of neutral and amino-acid transport in Ehrlich cells. Nature 197, 765-767. doi: 10.1038/197765a0
141. Padmanabhan Iyer, R., Gu, S., Nicholson, B. J., and Jiang, J. X. (2013). Identification of a disulfide bridge important for transport function of SNAT4 neutral amino acid transporter. PLoS ONE 8:e56792. doi: 10.1371/journal.pone.0056792
142. Palacin, M., and Kanai, Y. (2004). The ancillary proteins of HATs: SLC3 family of amino acid transporters. Pfiugers Arch. 447, 490-494. doi: 10.1007/s00424-003-1062-7
143. Palii, S. S., Chen, H., and Kilberg, M. S. (2004). Transcriptional control of the human sodium-coupled neutral amino acid transporter system a gene by amino acid availability is mediated by an intronic element. J. Biol. Chem. 279, 3463-3471. doi: 10.1074/jbc.M310483200
144. Palmada, M., Speil, A., Jeyaraj, S., Bohmer, C., and Lang, F. (2005). The serine/threonine kinases SGK1, 3 and PKB stimulate the amino acid transporter ASCT2. Biochem. Biophys. Res. Commun. 331, 272-277. doi: 10.1016/j.bbrc.2005.03.159
145. Palmieri, F. (2008). Diseases caused by defects of mitochondrial carriers: a review. Biochim. Biophys. Acta 1777, 564-578. doi: 10.1016/j.bbabio.2008.03.008
146. Park, S. Y., Kim, J. K., Kim, I. J., Choi, B. K., Jung, K. Y., Lee, S., et al. (2005). Reabsorption of neutral amino acids mediated by amino acid transporter LAT2 and TAT1 in the basolateral membrane of proximal tubule. Arch. Pharm. Res. 28, 421-432. doi: 10.1007/BF02977671
147. Patel, M., Dalvi, P., Gokulgandhi, M., Kesh, S., Kohli, T., Pal, D., et al. (2013). Functional characterization and molecular expression of large neutral amino acid transporter (LAT1) in human prostate cancer cells. Int. J. Pharm. 443, 245-253. doi: 10.1016/j.ijpharm.2012.12.029
148. Penmatsa, A., Wang, K. H., and Gouaux, E. (2013). X-ray structure of dopamine transporter elucidates antidepressant mechanism. Nature 503, 85-90. doi: 10.1038/nature12533
149. Pfeiffer, R., Rossier, G., Spindler, B., Meier, C., Kuhn, L., and Verrey, F. (1999). Amino acid transport of y+L-type by heterodimers of 4F2hc/CD98 and members of the glycoprotein-associated amino acid transporter family. EMBO J. 18, 49-57. doi: 10.1093/emboj/18.1.49
150. Pfeiffer, R., Spindler, B., Loffing, J., Skelly, P. J., Shoemaker, C. B., and Verrey, F. (1998). Functional heterodimeric amino acid transporters lacking cysteine residues involved in disulfide bond. FEBS Lett. 439, 157-162. doi: 10.1016/S0014-5793(98)01359-3
151. Pineda, M., Fernandez, E., Torrents, D., Estevez, R., Lopez, C., Camps, M., et al. (1999). Identification of a membrane protein, LAT-2, that Co-expresses with 4F2 heavy chain, an L-type amino acid transport activity with broad specificity for small and large zwitterionic amino acids. J. Biol. Chem. 274, 19738-19744. doi: 10.1074/jbc.274.28.19738
152. Pingitore, P., Pochini, L., Scalise, M., Galluccio, M., Hedfalk, K., and Indiveri, C. (2013). Large scale production of the active human ASCT2 (SLC1A5) transporter in Pichia pastoris-functional and kinetic asymmetry revealed in proteoliposomes. Biochim. Biophys. Acta 1828, 2238-2246. doi: 10.1016/j.bbamem.2013.05.034
153. Pochini, L., Scalise, M., Galluccio, M., and Indiveri, C. (2013). OCTN cation transporters in health and disease: role as drug targets and assay development. J. Biomol. Screen. 18, 851-867. doi: 10.1177/1087057113493006
154. Pochini, L., Seidita, A., Sensi, C., Scalise, M., Eberini, I., and Indiveri, C. (2014). Nimesulide binding site in the B0AT1 (SLC6A19) amino acid transporter.mechanism of inhibition revealed by proteoliposome transport assay and molecular modelling. Biochem. Pharmacol. 89, 422-430. doi: 10.1016/j.bcp.2014.03.014
155. Poncet, N., Mitchell, F. E., Ibrahim, A. F., McGuire, V. A., English, G., Arthur, J. S., et al. (2014). The catalytic subunit of the system L1 amino acid transporter (slc7a5) facilitates nutrient signalling in mouse skeletal muscle. PLoS ONE 9:e89547. doi: 10.1371/journal.pone.0089547
156. Pramod, A. B., Foster, J., Carvelli, L., and Henry, L. K. (2013). SLC6 transporters: structure, function, regulation, disease association and therapeutics. Mol. Aspects Med. 34, 197-219. doi: 10.1016/j.mam.2012.07.002
157. Prasad, P. D., Wang, H., Huang, W., Kekuda, R., Rajan, D. P., Leibach, F. H., et al. (1999). Human LAT1, a subunit of system L amino acid transporter: molecular cloning and transport function. Biochem. Biophys. Res. Commun. 255, 283-288. doi: 10.1006/bbrc.1999.0206
158. Rask-Andersen,M.,Masuram, S., Fredriksson, R., and Schioth, H. B. (2013). Solute carriers as drug targets: current use, clinical trials and prospective. Mol. Aspects Med. 34, 702-710. doi: 10.1016/j.mam.2012.07.015
159. Rathore, M. G., Saumet, A., Rossi, J. F., De Bettignies, C., Tempe, D., Lecellier, C. H., et al. (2012). The NF-kappaB member p65 controls glutamine metabolism through miR-23a. Int. J. Biochem. Cell Biol. 44, 1448-1456. doi: 10.1016/j.biocel.2012.05.011
160. Reyes, N., Ginter, C., and Boudker, O. (2009). Transport mechanism of a bacterial homologue of glutamate transporters. Nature 462, 880-885. doi: 10.1038/nature08616
161. Reynolds, M. R., Lane, A. N., Robertson, B., Kemp, S., Liu, Y., Hill, B. G., et al. (2014). Control of glutamine metabolism by the tumor suppressor Rb. Oncogene 33, 556-566. doi: 10.1038/onc.2012.635
162. Rooney, J. P. (2007). The role of thiols, dithiols, nutritional factors and interacting ligands in the toxicology of mercury. Toxi colog y 234, 145-156. doi: 10.1016/j.tox.2007.02.016
163. Rosell, A.,Meury,M., Alvarez-Marimon, E., Costa,M., Perez-Cano, L., Zorzano, A., et al. (2014). Structural bases for the interaction and stabilization of the human amino acid transporter LAT2 with its ancillary protein 4F2hc. Proc. Natl. Acad. Sci. U.S.A. 111, 2966-2971. doi: 10.1073/pnas.1323779111
164. Saha, P., Arthur, S., Kekuda, R., and Sundaram, U. (2012). Na-glutamine co-transporters B(0)AT1 in villus and SN2 in crypts are differentially altered in chronically infiamed rabbit intestine. Biochim. Biophys. Acta 1818, 434-442. doi: 10.1016/j.bbamem.2011.11.005
165. Sali, A., and Blundell, T. L. (1993). Comparative protein modelling by satisfaction of spatial restraints. J. Mol. Biol. 234, 779-815. doi: 10.1006/jmbi.1993.1626
166. Sastrasinh, S., and Sastrasinh, M. (1989). Glutamine transport in submitochondrial particles. Am.J.Physiol. 257, F1050-F1058.
167. Savas, S., Schmidt, S., Jarjanazi, H., and Ozcelik, H. (2006). Functional nsSNPs from carcinogenesis-related genes expressed in breast tissue: potential breast cancer risk alleles and their distribution across human populations. Hum. Genomics 2, 287-296. doi: 10.1186/1479-7364-2-5-287
168. Scalise, M., Pochini, L., Giangregorio, N., Tonazzi, A., and Indiveri, C. (2013). Proteoliposomes as tool for assaying membrane transporter functions and interactions with xenobiotics. Pharmaceutics 5, 472-497. doi: 10.3390/pharma-ceutics5030472
169. Schioth, H. B., Roshanbin, S., Hagglund, M. G., and Fredriksson, R. (2013). Evolutionary origin of amino acid transporter families SLC32, SLC36 and SLC38 and physiological, pathological and therapeutic aspects. Mol. Aspects Med. 34, 571-585. doi: 10.1016/j.mam.2012.07.012
170. Schneider, H. P., Broer, S., Broer, A., and Deitmer, J. W. (2007). Heterologous expression of the glutamine transporter SNAT3 in Xenopus oocytes is associated with four modes of uncoupled transport. J. Biol. Chem. 282, 3788-3798. doi: 10.1074/jbc.M609452200
171. Segawa, A., Nagamori, S., Kanai, Y., Masawa, N., and Oyama, T. (2013). L-type amino acid transporter 1 expression is highly correlated with Gleason score in prostate cancer. Mol. Clin. Oncol. 1, 274-280. doi: 10.3892/mco. 2012.54
172. Segawa, H., Fukasawa, Y., Miyamoto, K., Takeda, E., Endou, H., and Kanai, Y. (1999). Identification and functional characterization of a Na+-independent neutral amino acid transporter with broad substrate selectivity. J. Biol. Chem. 274, 19745-19751. doi: 10.1074/jbc.274.28.19745
173. Seow, H. F., Broer, S., Broer, A., Bailey, C. G., Potter, S. J., Cavanaugh, J. A., et al. (2004). Hartnup disorder is caused by mutations in the gene encoding the neutral amino acid transporter SLC6A19. Nat. Genet. 36, 1003-1007. doi: 10.1038/ng1406
174. Shaffer, P. L., Goehring, A., Shankaranarayanan, A., and Gouaux, E. (2009). Structure and mechanism of a Na+-independent amino acid transporter. Science 325, 1010-1014. doi: 10.1126/science.1176088
175. Shanware, N. P., Mullen, A. R., Deberardinis, R. J., and Abraham, R. T. (2011). Glutamine: pleiotropic roles in tumor growth and stress resistance. J. Mol.Med. (Berl) 89, 229-236. doi: 10.1007/s00109-011-0731-9
176. Shi, L., Luo, W., Huang, W., Huang, S., and Huang, G. (2013). Downregulation of L-type amino acid transporter 1 expression inhibits the growth, migration and invasion of gastric cancer cells. Oncol. Lett. 6, 106-112. doi: 10.3892/ol.2013.1342
177. Shi, Q., Padmanabhan, R., Villegas, C. J., Gu, S., and Jiang, J. X. (2011). Membrane topological structure of neutral system N/A amino acid transporter 4 (SNAT4) protein. J. Biol. Chem. 286, 38086-38094. doi: 10.1074/jbc.M111.220277
178. Shimizu, K., Kaira, K., Tomizawa, Y., Sunaga, N., Kawashima, O., Oriuchi, N., et al. (2014). ASC amino-acid transporter 2 (ASCT2) as a novel prognostic marker in non-small cell lung cancer. Br. J. Cancer 110, 2030-2039. doi: 10.1038/bjc.2014.88
179. Sidoryk, M., Matyja, E., Dybel, A., Zielinska, M., Bogucki, J., Jaskolski, D. J., et al. (2004). Increased expression of a glutamine transporter SNAT3 is a marker ofmalignant gliomas. Neuroreport 15, 575-578. doi: 10.1097/00001756-200403220-00001
180. Sloan, J. L., Grubb, B. R., and Mager, S. (2003). Expression of the amino acid transporter ATB 0+ in lung: possible role in luminal protein removal. Am. J. Physiol. Lung Cell. Mol. Physiol. 284, L39-L49. doi: 10.1152/ajplung.001 64.2002
181. Sloan, J. L., and Mager, S. (1999). Cloning and functional expression of a human Na(+) and Cl(-)-dependent neutral and cationic amino acid transporter B(0+). J. Biol. Chem. 274, 23740-23745. doi: 10.1074/jbc.274.34.23740
182. Solbu, T. T., Bjorkmo, M., Berghuis, P., Harkany, T., and Chaudhry, F. A. (2010). SAT1, A Glutamine transporter, is preferentially expressed in GABAergic neurons. Front. Neuroanat. 4:1. doi: 10.3389/neuro.05.001.2010
183. Son, J., Lyssiotis, C. A., Ying, H., Wang, X., Hua, S., Ligorio, M., et al. (2013). Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway. Nature 496, 101-105. doi: 10.1038/nature12040
184. Souba, W. W., Pan, M., and Stevens, B. R. (1992). Kinetics of the sodium-dependent glutamine transporter in human intestinal cell confiuent monolayers. Biochem. Biophys. Res. Commun. 188, 746-753. doi: 10.1016/0006-291X(92) 91119-B
185. Stumvoll, M., Perriello, G., Meyer, C., and Gerich, J. (1999). Role of glutamine in human carbohydrate metabolism in kidney and other tissues. Kidney Int. 55, 778-792. doi: 10.1046/j.1523-1755.1999.055003778.x
186. Sundberg, B. E.,Waag, E., Jacobsson, J. A., Stephansson, O., Rumaks, J., Svirskis, S., et al. (2008). The evolutionary history and tissue mapping of amino acid transporters belonging to solute carrier families SLC32, SLC36, and SLC38. J. Mol. Neurosci. 35, 179-193. doi: 10.1007/s12031-008-9046-x
187. Tonazzi, A., and Indiveri, C. (2003). Chemical modification of the mitochondrial ornithine/citrulline carrier by SH reagents: effects on the transport activity and transition from carrier to pore-like function. Biochim. Biophys. Acta 1611, 123-130. doi: 10.1016/S0005-2736(03)00033-6
188. Tonazzi, A., and Indiveri, C. (2011). Effects of heavy metal cations on the mitochondrial ornithine/citrulline transporter reconstituted in liposomes. Biometals 24, 1205-1215. doi: 10.1007/s10534-011-9479-5
189. Torchetti, E. M., Bonomi, F., Galluccio, M., Gianazza, E., Giancaspero, T. A., Iametti, S., et al. (2011). Human FAD synthase (isoform 2): a component of the machinery that delivers FAD to apo-flavoproteins. FEBS J. 278, 4434-4449. doi: 10.1111/j.1742-4658.2011.08368.x
190. Torres-Zamorano, V., Leibach, F. H., and Ganapathy, V. (1998). Sodium-dependent homo-and hetero-exchange of neutral amino acids mediated by the amino acid transporter ATB degree. Biochem. Biophys. Res. Commun. 245, 824-829. doi: 10.1006/bbrc.1998.8434
191. Utsunomiya-Tate, N., Endou, H., and Kanai, Y. (1996). Cloning and functional characterization of a system ASC-like Na+-dependent neutral amino acid transporter. J. Biol. Chem. 271, 14883-14890. doi: 10.1074/jbc.271.25.14883
192. Vander Heiden, M. G. (2011). Targeting cancer metabolism: a therapeutic window opens. Nat. Rev. Drug Discov. 10, 671-684. doi: 10.1038/nrd3504
193. Vander Heiden,M. G., Cantley, L. C., and Thompson, C. B. (2009). Understanding theWarburg effect: themetabolic requirements of cell proliferation. Science 324, 1029-1033. doi: 10.1126/science.1160809
194. Verrey, F. (2003). System L: heteromeric exchangers of large, neutral amino acids involved in directional transport. Pfiugers Arch. 445, 529-533. doi: 10.1007/s00424-002-0973-z
195. Verrey, F., Closs, E. I., Wagner, C. A., Palacin, M., Endou, H., and Kanai, Y. (2004). CATs and HATs: the SLC7 family of aminoacid transporters. Pfiugers Arch. 447, 532-542. doi: 10.1007/s00424-003-1086-z
196. Verrey, F., Ristic, Z., Romeo, E., Ramadan, T., Makrides, V., Dave, M. H., et al. (2005). Novel renal amino acid transporters. Annu. Rev. Physiol. 67, 557-572. doi: 10.1146/annurev.physiol.67.031103.153949
197. Verrey, F., Singer, D., Ramadan, T., Vuille-Dit-Bille, R. N., Mariotta, L., and Camargo, S.M. (2009). Kidney amino acid transport. Pfiugers Arch. 458, 53-60. doi: 10.1007/s00424-009-0638-2
198. Wagner, C. A., Lang, F., and Broer, S. (2001). Function and structure of heterodimeric amino acid transporters. Am.J.Physiol.CellPhysiol. 281, C1077-C1093.
199. Walker, D. K., Drummond, M. J., Dickinson, J. M., Borack, M. S., Jennings, K., Volpi, E., et al. (2014). Insulin increases mRNA abundance of the amino acid transporter SLC7A5/LAT1 via an mTORC1-dependent mechanism in skeletal muscle cells. Physiol. Rep. 2, e00238. doi: 10.1002/phy2.238
200. Wang, K., Cao, F., Fang, W., Hu, Y., Chen, Y., Ding, H., et al. (2013). Activation of SNAT1/SLC38A1 in human breast cancer: correlation with p-Akt overexpres-sion. BMC Cancer 13:343. doi: 10.1186/1471-2407-13-343
201. Wasa, M., Wang, H. S., and Okada, A. (2002). Characterization of L-glutamine transport by a human neuroblastoma cell line. Am.J.Physiol.CellPhysiol. 282, C1246-C1253. doi: 10.1152/ajpcell.00324.2001
202. Watanabe, J., Yokoyama, Y., Futagami, M., Mizunuma, H., Yoshioka, H., Washiya, K., et al. (2014). L-type amino acid transporter 1 expression increases in well-differentiated but decreases in poorly differentiated endometrial endometrioid adenocarcinoma and shows an inverse correlation with p53 expression. Int. J. Gynecol. Cancer 24, 659-663. doi: 10.1097/IGC.0000000000000123
203. Witte, D., Ali, N., Carlson, N., and Younes, M. (2002). Overexpression of the neutral amino acid transporter ASCT2 in human colorectal adenocarcinoma. Anticancer Res. 22, 2555-2557.
204. Xu, D., and Hemler,M. E. (2005).Metabolic activation-related CD147-CD98 complex. Mol. Cell. Proteomics 4, 1061-1071. doi: 10.1074/mcp.M400207-MCP200
205. Yamashita, A., Singh, S. K., Kawate, T., Jin, Y., and Gouaux, E. (2005). Crystal structure of a bacterial homologue of Na+/Cl-dependent neurotransmitter transporters. Nature 437, 215-223. doi: 10.1038/nature03978
206. Yanagisawa, N., Ichinoe, M., Mikami, T., Nakada, N., Hana, K., Koizumi, W., et al. (2012). High expression of L-type amino acid transporter 1 (LAT1) predicts poor prognosis in pancreatic ductal adenocarcinomas. J. Clin. Pathol. 65, 1019-1023. doi: 10.1136/jclinpath-2012-200826
207. Yernool, D., Boudker, O., Jin, Y., and Gouaux, E. (2004). Structure of a glutamate transporter homologue from Pyrococcus horikoshii. Nature 431, 811-818. doi: 10.1038/nature03018
208. Yoon, J. H., Kim, I. J., Kim, H., Kim, H. J., Jeong, M. J., Ahn, S. G., et al. (2005). Amino acid transport system L is differently expressed in human normal oral keratinocytes and human oral cancer cells. Cancer Lett. 222, 237-245. doi: 10.1016/j.canlet.2004.09.040
209. Zander, C. B., Albers, T., and Grewer, C. (2013). Voltage-dependent processes in the electroneutral amino acid exchanger ASCT2. J. Gen. Physiol. 141, 659-672. doi: 10.1085/jgp.201210948
210. Zhang, Z., Albers, T., Fiumera, H. L., Gameiro, A., and Grewer, C. (2009). A conserved Na(+) binding site of the sodium-coupled neutral amino acid transporter 2 (SNAT2). J. Biol. Chem. 284, 25314-25323. doi: 10.1074/jbc.M109. 038422
211. Ziegler, T. R., Bazargan, N., Leader, L.M., and Martindale, R. G. (2000). Glutamine and the gastrointestinal tract. Curr. Opin. Clin. Nutr. Metab. Care 3, 355-362. doi: 10.1097/00075197-200009000-00005